Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» February 2012
February 2012
FDA Accepts Impax Pharmaceuticals NDA Filing for IPX066 for the Treatment of Idiopathic Parkinson's Disease
FDA Accepts Impax Pharmaceuticals NDA Filing for IPX066 for the Treatment of Idiopathic Parkinson's Disease
PharmaLive
Impax Laboratories
Parkinson's Disease
Drug Companies Feel Price Pressure
Drug Companies Feel Price Pressure
PharmPro
drug pricing
1 Thing to Know Before Betting on the Next Blockbuster Drug
1 Thing to Know Before Betting on the Next Blockbuster Drug
Motley Fool
New J&J CEO must fix sullied image, integrate Synthes
New J&J CEO must fix sullied image, integrate Synthes
Yahoo/Reuters
JNJ
Synthes
BigPharma & Trust: Mostly Irrelevant
BigPharma & Trust: Mostly Irrelevant
Motley Fool
Glenmark Generics recalling birth control pills
Glenmark Generics recalling birth control pills
Yahoo/AP
Glenmark
generics
birth control
contraceptives
Warner Chilcott 4Q profit grows as charges fall
Warner Chilcott 4Q profit grows as charges fall
Yahoo/AP
Warner Chilcott
Biotech Investors, Take Note: Margin of Victory Matters
Biotech Investors, Take Note: Margin of Victory Matters
Motley Fool
Vivus's Qnexa And Its Potential Value
Vivus's Qnexa And Its Potential Value
Seeking Alpha
Vivus
Qnexa
obesity
weight loss
Not Just Any Biotech Stock Will Do
Not Just Any Biotech Stock Will Do
Motley Fool
PDL Biopharma
Amgen
Threshold Pharmaceuticals
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »